Lymph node-targeting adjuvant/neoantigen-codelivering vaccines for combination glioblastoma radioimmunotherapy is a research paper published in Theranostics (2023). On theSindex it has a DataRank of 0. It has been cited 7 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIAID NIH HHS
Grant: R01 AI168684
NINDS NIH HHS
Grant: R21 NS114455
NCI NIH HHS
Grant: R37 CA269249
NIGMS NIH HHS
Grant: R35 GM143014
NCI NIH HHS
Grant: R01 CA266981
NINDS NIH HHS
Grant: P30 NS047463
NCI NIH HHS
Grant: P30 CA016059
National Institutes of Health
Grant: 5R21NS114455-02
Glioblastoma radioimmunotherapy
National Institutes of Health
Grant: 5R01AI168684-02
Small circular mRNA vaccines
National Institutes of Health
Grant: 7R35GM143014-03
Nucleic Acid Modulators and Theranostics for ADAR
National Institutes of Health
Grant: 5P30NS047463-03
Core--Imaging and stereology facility
National Institutes of Health
Grant: 7R01CA266981-02
Lymph Node-Targeted Codelivery of Albumin-Binding Peptide Antigens and Di-Adjuvant for Melanoma Combination Immunotherapy
National Institutes of Health
Grant: 4P30CA016059-35
Massey Cancer Center Support Grant
FWCI
0.00
Citation Percentile
0.0%
Fields of Study
MeSH Terms
Keywords